| DISC1 and PDE4B are interacting genetic factors in schizophrenia that regulate cAMP signaling JK Millar, BS Pickard, S Mackie, R James, S Christie, SR Buchanan, ... Science 310 (5751), 1187-1191, 2005 | 756 | 2005 |
| Targeting of cyclic AMP degradation to β2-adrenergic receptors by β-arrestins SJ Perry, GS Baillie, TA Kohout, I McPhee, MM Magiera, KL Ang, ... Science 298 (5594), 834-836, 2002 | 608 | 2002 |
| Matrix polymers of Candida biofilms and their possible role in biofilm resistance to antifungal agents GS Baillie, LJ Douglas Journal of Antimicrobial Chemotherapy 46 (3), 397-403, 2000 | 537 | 2000 |
| Sleep deprivation impairs cAMP signalling in the hippocampus CG Vecsey, GS Baillie, D Jaganath, R Havekes, A Daniels, M Wimmer, ... Nature 461 (7267), 1122-1125, 2009 | 470 | 2009 |
| Mixed species biofilms of Candida albicans and Staphylococcus epidermidis B Adam, GS Baillie, LJ Douglas Journal of medical microbiology 51 (4), 344-349, 2002 | 465 | 2002 |
| Apremilast, a cAMP phosphodiesterase‐4 inhibitor, demonstrates anti‐inflammatory activity in vitro and in a model of psoriasis PH Schafer, A Parton, AK Gandhi, L Capone, M Adams, L Wu, JB Bartlett, ... British journal of pharmacology 159 (4), 842-855, 2010 | 463 | 2010 |
| β-Arrestin-mediated PDE4 cAMP phosphodiesterase recruitment regulates β-adrenoceptor switching from Gs to Gi GS Baillie, A Sood, I McPhee, I Gall, SJ Perry, RJ Lefkowitz, MD Houslay Proceedings of the National Academy of Sciences 100 (3), 940-945, 2003 | 454 | 2003 |
| Role of dimorphism in the development of Candida albicans biofilms GS Baillie, LJ Douglas Journal of medical microbiology 48 (7), 671-679, 1999 | 417 | 1999 |
| cAMP-Specific phosphodiesterase-4 enzymes in the cardiovascular system: a molecular toolbox for generating compartmentalized cAMP signaling MD Houslay, GS Baillie, DH Maurice Circulation research 100 (7), 950-966, 2007 | 368 | 2007 |
| Effect of Growth Rate on Resistance ofCandida albicans Biofilms to Antifungal Agents GS Baillie, LJ Douglas Antimicrobial agents and chemotherapy 42 (8), 1900-1905, 1998 | 335 | 1998 |
| The MAP kinase ERK2 inhibits the cyclic AMP-specific phosphodiesterase HSPDE4D3 by phosphorylating it at Ser579 R Hoffmann, GS Baillie, SJ MacKenzie, SJ Yarwood, MD Houslay The EMBO journal 18 (4), 893-903, 1999 | 322 | 1999 |
| Long PDE4 cAMP specific phosphodiesterases are activated by protein kinase A-mediated phosphorylation of a single serine residue in Upstream Conserved Region 1 (UCR1) SJ MacKenzie, GS Baillie, I McPhee, C MacKenzie, R Seamons, ... British journal of pharmacology 136 (3), 421, 2002 | 282 | 2002 |
| ERK2 mitogen-activated protein kinase binding, phosphorylation, and regulation of the PDE4D cAMP-specific phosphodiesterases: the involvement of COOH-terminal docking sites and … SJ MacKenzie, GS Baillie, I McPhee, GB Bolger, MD Houslay Journal of Biological Chemistry 275 (22), 16609-16617, 2000 | 271 | 2000 |
| Compartmentalized signalling: spatial regulation of cAMP by the action of compartmentalized phosphodiesterases GS Baillie The FEBS journal 276 (7), 1790-1799, 2009 | 267 | 2009 |
| Compartmentalisation of phosphodiesterases and protein kinase A: opposites attract GS Baillie, JD Scott, MD Houslay FEBS letters 579 (15), 3264-3270, 2005 | 260 | 2005 |
| RNA silencing identifies PDE4D5 as the functionally relevant cAMP phosphodiesterase interacting with βarrestin to control the protein kinase A/AKAP79-mediated switching of the … MJ Lynch, GS Baillie, A Mohamed, X Li, C Maisonneuve, E Klussmann, ... Journal of Biological Chemistry 280 (39), 33178-33189, 2005 | 242 | 2005 |
| Protein kinase A type I and type II define distinct intracellular signaling compartments G Di Benedetto, A Zoccarato, V Lissandron, A Terrin, X Li, MD Houslay, ... Circulation research 103 (8), 836-844, 2008 | 240 | 2008 |
| Sleep deprivation causes memory deficits by negatively impacting neuronal connectivity in hippocampal area CA1 R Havekes, AJ Park, JC Tudor, VG Luczak, RT Hansen, SL Ferri, ... Elife 5, e13424, 2016 | 237 | 2016 |
| Therapeutic targeting of 3′, 5′-cyclic nucleotide phosphodiesterases: inhibition and beyond GS Baillie, GS Tejeda, MP Kelly Nature reviews Drug discovery 18 (10), 770-796, 2019 | 236 | 2019 |
| Production of extracellular matrix by Candida albicans biofilms SP Hawser, GS Baillie, LJ Douglas Journal of medical microbiology 47 (3), 253-256, 1998 | 234 | 1998 |
Dr Martin J LynchUKHSA GenomicsVerified email at ukhsa.gov.uk
